(EYPT) Eyepoint - Performance -47.2% in 12m
Compare EYPT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-28.27%
#79 in Group
Rel. Strength
7.08%
#7394 in Universe
Total Return 12m
-47.23%
#158 in Group
Total Return 5y
-30.96%
#80 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: EYPT (-47.2%) vs XLV (-4.1%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: EYPT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for EYPT
Total Return (including Dividends) | EYPT | XLV | S&P 500 |
---|---|---|---|
1 Month | 47.70% | 0.87% | 13.81% |
3 Months | -2.71% | -7.96% | -6.30% |
12 Months | -47.23% | -4.06% | 10.65% |
5 Years | -30.96% | 43.49% | 107.77% |
Trend Score (consistency of price movement) | EYPT | XLV | S&P 500 |
1 Month | 71.4% | -8.1% | 83% |
3 Months | -10.6% | -75.3% | -75.3% |
12 Months | -76.8% | -28.8% | 50.1% |
5 Years | 5.20% | 89.7% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #12 | 46.4% | 29.8% |
3 Month | #59 | 5.70% | 3.83% |
12 Month | #158 | -45.0% | -52.3% |
5 Years | #82 | -51.9% | -66.8% |
FAQs
Does EYPT Eyepoint outperforms the market?
No,
over the last 12 months EYPT made -47.23%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months EYPT made -2.71%, while XLV made -7.96%.
Over the last 3 months EYPT made -2.71%, while XLV made -7.96%.
Performance Comparison EYPT vs Indeces and Sectors
EYPT vs. Indices EYPT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -15.6% | 33.9% | -42.6% | -57.9% |
US NASDAQ 100 | QQQ | -15.8% | 30.3% | -42.8% | -58.9% |
US Dow Jones Industrial 30 | DIA | -16.0% | 37.7% | -42.3% | -54.9% |
German DAX 40 | DAX | -15.6% | 32.7% | -68.9% | -72.9% |
Shanghai Shenzhen CSI 300 | CSI 300 | -17.8% | 35.9% | -43.4% | -54.6% |
Hongkong Hang Seng | HSI | -18.8% | 27.8% | -51.0% | -60.9% |
India NIFTY 50 | INDA | -10.7% | 42.9% | -43.1% | -47.0% |
Brasil Bovespa | EWZ | -16.7% | 30.5% | -51.3% | -38.9% |
EYPT vs. Sectors EYPT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -16.3% | 34.3% | -49.7% | -68.8% |
Consumer Discretionary | XLY | -16.0% | 33.5% | -41.6% | -61.5% |
Consumer Staples | XLP | -14.8% | 41.1% | -49.5% | -56.4% |
Energy | XLE | -15.5% | 40.9% | -36.0% | -37.8% |
Financial | XLF | -16.7% | 34.2% | -49.7% | -69.7% |
Health Care | XLV | -12.6% | 46.8% | -37.6% | -43.2% |
Industrial | XLI | -17.3% | 30.9% | -44.0% | -58.2% |
Materials | XLB | -15.4% | 34.1% | -37.7% | -42.0% |
Real Estate | XLRE | -14.3% | 36.2% | -43.4% | -62.7% |
Technology | XLK | -16.7% | 26.5% | -39.7% | -54.3% |
Utilities | XLU | -15.7% | 38.1% | -50.3% | -64.7% |
Aerospace & Defense | XAR | -17.6% | 26.5% | -54.1% | -74.6% |
Biotech | XBI | -9.04% | 35.9% | -22.5% | -34.9% |
Homebuilder | XHB | -16.1% | 36.2% | -29.4% | -39.7% |
Retail | XRT | -17.5% | 33.1% | -38.4% | -45.8% |